Brazilian mystic Athos Salomé, 39, has made numerous accurate predictions over the years, including the onset of the ...

From immune cell therapies to measles outbreaks to federal attacks on public health, these are some of the health topics ...

Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy by harnessing the body's immune system to target ...

Amazon ( AMZN +0.06%) continues to underscore the strength of its business and deliver fantastic growth for long-term ...

Advances delivered what may feel like medical miracles, including the first bladder transplant, a lifesaving personalized ...

Immense progress in gene editing, drug discovery and conservation are just some of the reasons to be cheerful about 2025 ...

A dire wolf de-extinction debate, CRISPR-GPT for gene editing, and more topped the list of our most popular stories in ...

VESALIUS-CV was big in 2025, but studies looking at triglycerides, CRISPR, and oral GLP-1s also made the highlight reel.

It was the best of times, it was the worst of times for research in 2025. | It was the best of times and it was the worst of times for research in 2025. Medical breakthroughs and stunning discoveries ...

A push to reshore some drug production and progress in advanced manufacturing technologies have been prominent trends this year, industry leaders say.

CRISPR Therapeutics shares early autoimmune and lymphoma data for zugo-cel, showing strong responses, manageable safety, and expanded oncology plans.

Now, Musunuru and colleagues are preparing a master clinical protocol to study a CRISPR therapy that's mostly the same as the one they used to treat baby KJ, except they plan to swap out the gene ...